Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 5851-5860 of 11739

Edit search filters
  1. The LEADLESS II IDE Study (Phase II): A Safety And Effectiveness Trial For A Leadless Pacemaker System

    Rochester, MN

  2. Safety And Efficacy Of Momelotinib In Subjects With Polycythemia Vera Or Essential Thrombocythemia

    Scottsdale/Phoenix, AZ

  3. A Study Of BBI608 In Adult Patients With Advanced Colorectal Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  4. Veri-T: A Trial Of Verdiperstat In Patients With SvPPA Due To TDP-43 Pathology (Veri-T-001)

    Rochester, MN

  5. A Study Comparing BGB-3111 And Ibrutinib In Subjects With Waldenström's Macroglobulinemia (WM)

    Scottsdale/Phoenix, AZ, Rochester, MN

  6. Efficacy, Safety And Pharmacokinetics Of Topical Timolol In Infants With Infantile Hemangioma (IH)

    Rochester, MN

  7. Irinotecan And Cetuximab With Or Without Bevacizumab In Treating Patients With RAS Wild-Type Locally Advanced Or Metastatic Colorectal Cancer That Cannot Be Removed By Surgery

    Scottsdale/Phoenix, AZ

  8. Atezolizumab, Pemetrexed Disodium, Cisplatin, And Surgery With Or Without Radiation Therapy In Treating Patients With Stage I-III Pleural Malignant Mesothelioma

    Scottsdale/Phoenix, AZ, Rochester, MN

  9. An Open-Label Safety And Tolerability Study Of INCB062079 In Subjects With Advanced Hepatocellular Carcinoma And Other Malignancies

    Scottsdale/Phoenix, AZ

  10. Avelumab In Combination Regimens That Include An Immune Agonist, Epigenetic Modulator, CD20 Antagonist And/or Conventional Chemotherapy In Patients With Relapsed Or Refractory Diffuse Large B-cell Lymphoma (R/R DLBCL)

    Rochester, MN

.

Mayo Clinic Footer